Now more than ever, it is critical that anyone contemplating investment in a healthcare sector carefully review the target company’s compliance protocols. We have always strongly recommended that investors analyze the company’s compliance program, as well as efforts at adhering to
healthcare reform
Key Issues re Investment in the Dialysis Industry
By Amber Walsh on
On Wednesday, March 12th, McGuireWoods hosted our 8th Annual Business & Legal Issues in Dialysis & Nephrology Symposium. Leaders from various perspectives in the industry provided presentations and lead discussions on a wide array of topics, including the …
Continue Reading Key Issues re Investment in the Dialysis Industry
Transparency Initiatives in Health Reform Bring Burdens and Opportunities
Posted on
Posted in Life Sciences Investing
The Patient Protection and Affordable Healthcare Act (commonly known as the "healthcare reform" bill) includes significant new transparency and disclosure obligations that apply to physicians, hospitals, and medical device and pharmaceutical manufacturers.
Some of these transparency and disclosure obligations are…
Continue Reading Transparency Initiatives in Health Reform Bring Burdens and Opportunities
Healthcare Reform Update: U.S. House Votes to Approve Senate Bill and Reconciliation Bill
By Amber Walsh on
Yesterday, the House voted in two separate votes to approve healthcare reform legislation. In a vote of 219-212, the House approved the healthcare reform bill that was passed by the Senate on Christmas Eve. Then, in a vote of 220-211, the House approved